Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
31 Oct 2024
Tackling Infectious Diseases
This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
31 Oct 2024
AML Expert-Led Webinar: Exploring Maintenance Approaches in AML
Watch Part 2 of the Expert Webinar series on acute myeloid leukaemia (AML) maintenance therapy (catch up on Part 1 of the…
30 Oct 2024
Potential Survival Benefits of Transplant for TP53-Mutated Acute Myeloid Leukemia
A recent multicenter study led by researchers including Talha Badar and Moazzam Shahzad has highlighted the challenging prognosis of TP53-mutated acute myeloid leukemia.
30 Oct 2024
Low FOXP3+ Cell Count Linked to Poor Outcomes in Rare T Cell Lymphoma
Low levels of FOXP3+ regulatory T cells are associated with worse progression-free survival and more aggressive disease characteristics in patients with angioimmunoblastic T cell lymphoma.
30 Oct 2024
Hema Now: Episode 3: Reflections on the EHA Congress
In this episode of Hema Now, Dr. Jonathan Sackier welcomes Professor Antonio Almeida, a leader in hematology and the 2024 President of the EHA.
27 Oct 2024
Optimal Treatment Strategies for Sjögren's Disease-Associated Lymphoma Revealed
A new study has highlighted the optimal treatment strategies for managing non-Hodgkin lymphoma in patients with Sjögren’s disease
26 Oct 2024
Study Reveals Mechanisms of Platelet FXIII-A Retention During Activation
A new study has revealed insights into the behaviour of platelet factor XIII-A, a major cytoplasmic protein, during platelet activation.
24 Oct 2024
Epigenetic Test May Predict Immunotherapy Success in Multiple Myeloma
Researchers have made a significant discovery that could one day help tailor immunotherapy treatments for patients with multiple myeloma.
Loading posts...
« Previous
1
…
32
33
34
35
36
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View